Annual General Meeting of BioGaia

Regulatory News:

The Annual General Meeting of BioGaia AB (STO:BIOGB) (publ) on 10 May 2016 voted to approve the following resolutions:

· adoption of the annual report

· discharge from liability for the Board members and the Managing Director

· a dividend of SEK 5.00 per share

· re-election of Board members Jan Annwall, Ewa Björling, David Dangoor, Stefan Elving, Inger Holmström, Anthon Jahreskog, Brit Stakston and Paula Zeilon

· re-election of David Dangoor as Board Chairman

· re-election of the registered Accounting firm Deloitte AB

· Board member compensation in an amount of SEK 300,000 to the Chairman and SEK 150,000 to each of the other Board members not employed by the company

· auditors’ fee shall be paid according to approved account

· regarding principles for remuneration and other terms of employment for senior executives in accordance with the Board’s proposal

· regarding the Nominating Committee in accordance with the Nominating Committee’s proposal

Latest press releases from BioGaia

2016-05-10 BioGaia AB Interim management statement 1 January – 31 March 2016

2016-05-02 Yet another meta-analysis confirms the effectiveness of BioGaia’s probiotic in infantile colic

2016-04-27 BioGaia guarantees rights issue in IBT

BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of NASDAQ Stockholm main market. www.biogaia.com

(http://www.biogaia.com)

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160510007097/en/